Muscle mass may change how chemo is given
NCT ID NCT05183126
First seen Mar 07, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study looks at whether giving the chemotherapy drug paclitaxel over a longer time (2-3 hours) to cancer patients with low muscle mass can make the drug level in their blood similar to patients with normal muscle mass who get the standard 1-hour infusion. About 22 women with breast, stomach, or esophageal cancer will take part. The goal is to learn how to personalize dosing, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Conditions
Explore the condition pages connected to this study.